BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Conformité Européenne (CE) Marked BD Onclarity™ HPV Assay for the BD COR™ System and the BD Viper™ LT System have been accepted for the World Health Organization (WHO) list of prequalified in vitro diagnostic products, further expanding access […]

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

(CNSX:DRUG.CN),(CNSX:DRUG),(NASDAQ:DRUG), — Tania Markovic MBBS PhD FRACP; Jennifer L. Miller, MD; Elizabeth Roof, H.S.P., M.A.; and Theresa V. Strong, PhD; distinguished global experts in PWS, will support the Company's PWS program, which was announced on November 6, 2025 — NEW YORK and VANCOUVER, British Columbia, Nov. 17, 2025 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc.

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS) GlobeNewswire November 17, 2025 — Tania Markovic MBBS PhD FRACP; Jennifer L. Miller, MD; Elizabeth Roof, H.S.P., M.A.; and Theresa V. Strong, PhD; distinguished global experts in PWS, will support the Company's PWS program, which was announced on November 6,

Legal-Bay Offers Holiday Cash Advances to Plaintiffs Awaiting Settlements

Premier pre-settlement funding company prepares for seasonal demand as clients seek extra cash for gifts, travel, and holiday expenses. Legal-Bay LLC, the Pre-Settlement Funding Company, announced today that they are gearing up for a busy holiday season as more plaintiffs turn to lawsuit funding to help cover increased expenses. With inflation continuing to impact household

Target Hospitality Expands Data Center Community by 160% to Meet Accelerating Customer Demand

Target Hospitality Corp. (“Target Hospitality”, “Target” or the “Company”) (Nasdaq: TH), one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services,today announced a 400-bed community expansion (“Community Expansion” or the “Expansion”) to the previously announced 250-bed data center community (“Data Center Community” or the “Community”). The Community Expansion represents a

WALOVI International Cans Make Malaysian Debut, Shining at Fortune Innovation Forum

On November 17, 2025, at the Fortune Innovation Forum held in Kuala Lumpur,Guangzhou Wang Lao Ji Great Health Industry Co., Ltd., under Guangzhou Pharmaceutical Holdings Limited, grandly launched its WALOVI international cans in the Malaysian market. Following its successful launch in Singapore on November 7, this move represents another crucial strategic deployment for Wanglaoji within

Red Cross: Community responders provide lifeline amid 2025 emergencies

Donate at redcross.org to support disaster survivors, hospital patients and military families As disasters surged across the U.S. in 2025, community responders became a lifeline forthousands needing shelter, food and emotional support. In a powerful display of humanity, volunteers – who make up 90% of the American Red Cross workforce – joined forces with community

Jones Soda Reports Third Quarter 2025 Results

Jones Soda Co. (CSE: JSDA) (OTCQB: JSDA) (“Jones Soda” or the “Company”), today announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Summary vs. Year-Ago Quarter — Revenue increased by 15% to $4.5 million compared to $3.9 million. — Net loss was $1.4 million, or $(0.01) per share,

Wyndham Hotels & Resorts Appoints Alexandra A. Jung to Board of Directors

Wyndham Hotels & Resorts (NYSE: WH), the world's largest hotel franchisor, today appointed Alexandra A. Jung to its Board of Directors. Ms. Jung will serve as a member of the Corporate Governance and Audit Committees. https://mma.prnewswire.com/media/2824205/Wyndham_Alexandra_A_Jung.jpg “With vast experience across oceans and corporate sectors, Alex is an experienced business builder and leader with deep global

Nuvalent Announces Positive Topline Pivotal Data from ALKOVE-1 Clinical Trial of Neladalkib for TKI Pre-treated Patients with Advanced ALK-positive NSCLC

— In 253 ALK TKI pre-treated patients, ORR by BICR was 31% (95% CI: 26, 37), with initial estimated durability of response of 64% and 53% at the 12-month and 18-month landmarks, respectively — In the subset of 63 TKI pre-treated patients who were lorlatinib-naïve, ORR by BICR was 46% (95% CI: 33, 59), with

Scroll to Top